Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eram Haider

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Handbook of Experimental Pharmacology|June 15, 2022
Precision Medicine in DiabetesAdem Y Dawed, Eram Haider, Ewan R Pearson
Communications Medicine|October 4, 2023
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic reviewKatherine G Young, Eram Haider McInnes, Robert J Massey, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitorsKatherine G Young, Eram Haider McInnes, Robert J Massey, et al.
Diabetologia|February 22, 2024
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetesPedro Cardoso, Katie G Young, Anand T N Nair, et al.
Nature Medicine|October 4, 2023
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicineDeirdre K Tobias, Jordi Merino, Abrar Ahmad, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Handbook of Experimental Pharmacology|June 15, 2022
Precision Medicine in DiabetesAdem Y Dawed, Eram Haider, Ewan R Pearson
Communications Medicine|October 4, 2023
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic reviewKatherine G Young, Eram Haider McInnes, Robert J Massey, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitorsKatherine G Young, Eram Haider McInnes, Robert J Massey, et al.
Diabetologia|February 22, 2024
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetesPedro Cardoso, Katie G Young, Anand T N Nair, et al.
Nature Medicine|October 4, 2023
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicineDeirdre K Tobias, Jordi Merino, Abrar Ahmad, et al.
Pageof 1